Identification of Protein and Genetic Biomarkers of Prostate Cancer and Risk Factors for Progression of Disease
The purpose of this study is to identify genetic variants that predict progression of prostate cancer.
The purpose of this study is to identify genetic variants that predict progression of prostate cancer.
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
This phase II trial studies how well radiation therapy with or without apalutamide works in treating patients with stage III-IV prostate cancer. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgen can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may lessen the amount of androgen made by the body. Giving radiation therapy and apalutamide may work better at treating prostate cancer than radiation alone.
If you have prostate cancer, your doctor may recommend surgery to remove the prostate gland. At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, you’re in the hands of leading prostate cancer experts. Our team includes surgeons with fellowship training focused on prostate cancer surgery. We have specialized expertise in removing cancer using robotics technology (called a robotic prostatectomy). This precise technique helps us treat cancer with less impact on your life.
Brachytherapy, also called internal radiation therapy, can effectively treat certain cancers, such as cervical and prostate cancers, in novel ways. At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, you receive care from skilled experts who are leaders in their field. Our experienced radiation oncologists perform intricate brachytherapy procedures with your safety and comfort in mind at all times.
At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our team pioneered the use of intensity-modulated radiation therapy (IMRT) decades ago. Today, our experts use IMRT to treat certain cancers, such as prostate and lung cancers, with incredible precision. IMRT’s increased effectiveness — with fewer side effects — offers new possibilities for what you can do during and after cancer treatment.